R Foa Selected Research

Neoplasms (Cancer)

2/2000	Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures.
1/2000	Chronic myeloid leukemia cells resistant to interferon-alpha lack STAT1 expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Foa Research Topics

Disease

2	Leukemia 07/2014 - 02/2000
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2000 - 03/2000
2	Neoplasms (Cancer) 02/2000 - 01/2000
1	Multiple Myeloma 01/2017
1	Necrosis 04/2001
1	Chromosome Aberrations (Chromosome Abnormalities) 02/2001
1	Residual Neoplasm 09/2000
1	Infections 05/2000
1	Multiple Abnormalities 03/2000
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2000

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 07/2014 - 02/2000
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2017
1	Bortezomib (Velcade)FDA Link 01/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2001
1	DNA (Deoxyribonucleic Acid)IBA 02/2001
1	fludarabineIBA 09/2000
1	SteroidsIBA 05/2000
1	Interleukin-7 (Interleukin 7)IBA 02/2000
1	Interleukin-2 (IL2)IBA 02/2000
1	Interferon-alpha (Interferon Alfa)IBA 01/2000

Therapy/Procedure

1	Therapeutics 09/2000
1	Transplantation 09/2000